Skip to content

Circadian Rhythm in Kidney Transplantation.

Circadian Rhythm in Kidney Transplantation -01.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22422
Enrollment
70
Registered
2011-07-12
Start date
2011-04-27
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney transplantation circadian rhythm sleep disturbances ambulatory blood pressure Dutch: niertransplantatie, circadiane ritmiek, slaapstoornissen, 24u-bloeddruk

Interventions

The course of the circadian rhythms of melatonin, ambulatory blood pressure, body temperature and sleep are measured in kidney transplant recipients and their living kidney donors before and after kid

Sponsors

VU University Medical Centre, Amsterdam, The Netherlands Meander Medical Centre, Amersfoort, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Kidney recipients: 1. Aged 18-85 yr, both male and female; 2. Living donor transplantation; 3. Good understanding of dutch language; 4. Informed consent. Kidney donors: 1. Aged 18-85 yr, both male and female; 2. Good understanding of dutch language; 3. Informed consent.

Exclusion criteria

Exclusion criteria: Both recipients and donors: 1. Use of hypnotics/melatonin during study measurements; 2. Relevant co-morbidity that interferes with participation in the study according to the investigators (e.g. heart failure NYHA class IV, instable AP, pulmonary, psychiatric, neurologic, blindness); 3. Documented sleep apnea; 4. Alcohol / drug abuse.

Design outcomes

Primary

MeasureTime frame
Recurrence of the 'dim light melatonin onset' (DLMO) after kidney transplantation in kidney transplant recipients. Definition of the DLMO: melatonin concentration peak >4 pg/ml saliva, between 7 and 12 pm.

Secondary

MeasureTime frame
1. Change in subjective and objective sleep parameters; 2. Circadian body temperature; 3. Ambulant blood pressure profile; 4. Quality of life.

Contacts

Public ContactM. Russcher

Meander Medical Centre dept. Hospital Pharmacy PO Box 1502

M.Russcher@meandermc.nl+31 (0)33 8501720

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)